v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Total revenues $ 22 $ 730 $ 37 $ 1,424
Operating expenses:        
Research and development 67,542 54,196 140,543 106,810
General and administrative 13,103 10,391 24,552 21,211
Total operating expenses 80,645 64,587 165,095 128,021
Operating loss (80,623) (63,857) (165,058) (126,597)
Investment and other income, net 7,120 7,257 12,870 16,201
Net loss $ (73,503) $ (56,600) $ (152,188) $ (110,396)
Basic net loss per common share (in dollars per share) $ (0.94) $ (0.85) $ (2.11) $ (1.66)
Diluted net loss per common share (in dollars per share) $ (0.94) $ (0.85) $ (2.11) $ (1.66)
Shares used in calculating basic net loss per share (in shares) 77,840 66,392 72,234 66,388
Shares used in calculating diluted net loss per share (in shares) 77,840 66,392 72,234 66,388
Comprehensive loss:        
Net loss $ (73,503) $ (56,600) $ (152,188) $ (110,396)
Other comprehensive (loss) income:        
Unrealized (loss) gain on marketable securities (1,224) (229) (2,328) 25
Comprehensive loss (74,727) (56,829) (154,516) (110,371)
Product development and licensing agreements        
Revenues:        
Total revenues 7 7 7 57
Contracts and grants        
Revenues:        
Total revenues $ 15 $ 723 $ 30 $ 1,367